SEC Form 4 · accession 0001209191-18-039678

Kezar Life Sciences, Inc. · KZR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 25, 2018

Accepted (ET)

Jun 27, 2018 · 4:54 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001645666

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jun 25, 2018	C	52,581	—	A	143,182	I	By JPM Partners, LLC
Common Stock^F1	Jun 25, 2018	C	35,258	—	A	178,440	I	By JPM Partners, LLC

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Convertible Perferred Stock^F1	—	Jun 25, 2018	C	52,581	D	—	—	Common Stock	52,581	0	I
Series B Convertible Perferred Stock^F1	—	Jun 25, 2018	C	35,258	D	—	—	Common Stock	35,258	0	I

F1Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.